Belite Bio Inc ADR（BLTE）— 同業公司組
數據截至2026-10-30 — 評分每個交易日晚間重新計算。分組標準＝首先為共同的Closelook指數成分，其次為產業。Closelook研究日記，不構成投資建議。
Belite Bio Inc ADR的Closelook綜合評分為27/100，在同業公司組內排名第7位（共7家）——組內評分最高的是BB Biotech AG（74/100）。
| 名稱 | 綜合 | 動能 | 品質 | 估值 | 訊號 | 距52週高點 |
|---|---|---|---|---|---|---|
| BLTE Belite Bio Inc ADR | 27 | 53 | 7 | 9 | info | 22.6% |
| BION.SW BB Biotech AG | 74 | 71 | 96 | 81 | info | 10% |
| HALO Halozyme Therapeutics Inc | 73 | 98 | 94 | 39 | ok | 2.3% |
| ONC BeiGene, Ltd. | 65 | 86 | 64 | 31 | ok | 4.7% |
| UCB.BR UCB SA | 65 | 70 | 71 | 54 | info | 2.4% |
| ARGX.BR Argen-X | 64 | 79 | 75 | 29 | info | 12.7% |
| ARGX argenx NV ADR | 63 | 73 | 74 | 29 | info | 16.8% |
FAQ · from the current data · as of 2026-10-30
Quick answers
Belite Bio Inc ADR在Closelook涵蓋範圍內的同業公司有哪些？
分組首先根據共同的Closelook指數成分，其次根據產業：BB Biotech AG (BION.SW)、Halozyme Therapeutics Inc (HALO)、BeiGene, Ltd. (ONC)、UCB SA (UCB.BR)、Argen-X (ARGX.BR)、argenx NV ADR (ARGX)。
BLTE相對同業公司的評分如何？
Belite Bio Inc ADR的綜合評分為27/100，組內排名第7位（共7家），截至2026-10-30；組內最高綜合評分為BB Biotech AG（74/100）。Closelook評分為研究日記讀數，不構成評等或投資建議。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry